Market Cap

Xintela AB Market Capitalization:

kr155.9 Million

SEK as of Jan. 1, 2024

US$15.5 Million

business Xintela AB Company Profile

Xintela AB Main Stock Listing

OMX: XINT

Market Capitalization History of Xintela AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Xintela AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr155.9 M -3.00%
Jan. 1, 2023 kr160.8 M -77.89%
Jan. 1, 2022 kr727.0 M -28.12%
Jan. 1, 2021 kr1.01 B -29.02%
Jan. 1, 2020 kr1.42 B -42.58%
Jan. 1, 2019 kr2.48 B 129.94%
Jan. 1, 2018 kr1.08 B -32.11%
Jan. 1, 2017 kr1.59 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Xintela AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Xintela AB has the following listings and related stock indices.


Stock: OMX: XINT

Stock: FSX: 1XT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.